Published

Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuroscience applied
Date: 2024-01-01
Source: PubMed
DOI: 10.1016/j.nsa.2023.103929
PubMed: 40656118

Authors

McCulloch DE Lopez JP Dalla C Castrén E Erritzoe D Frokjaer VG Lundberg J Preller KH Fisher PM Knudsen GM

Watch author

Derived topics and classifications

psilocybin Brain Imaging Mechanism of Action Receptor Pharmacology Aging Animal Study Animal Study

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.2024-01-01

Related papers

Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapyJournal of Psychedelic Studies · 2026-08-13 The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14 An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10 Evaluating psilocybin for the management of depression: a literature reviewBritish Journal of Mental Health Nursing · 2026-08-02 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 Advanced research eyes potential of psychedelics for complex casesMental Health Weekly · 2026-08-07 A suite of engineered mice for interrogating psychedelic drug actions.Nature neuroscience · 2026-08-06